(Q37449288)

20 August 2017

Expressions of matrix metalloproteinase-7 and -9 and their prognostic significances in rectal cancer (English)

1 reference

20 August 2017

Young Rak Cho

1

1 reference

20 August 2017

Hyuk-Chan Kwon

2

1 reference

20 August 2017

Sung-Hwan Suh

3

1 reference

20 August 2017

Jong Hoon Lee

4

1 reference

20 August 2017

Sung-Hyun Kim

5

1 reference

20 August 2017

Hong-Jo Choi

6

1 reference

20 August 2017

Hyung-Sik Lee

7

1 reference

20 August 2017

Mee Sook Roh

8

1 reference

20 August 2017

Tae-Ho Hwang

9

1 reference

20 August 2017

Jae-Seok Kim

10

1 reference

20 August 2017

Hyo-Jin Kim

11

1 reference

20 August 2017

31 December 2005

1 reference

Cancer Research and Treatment

20 August 2017

1 reference

20 August 2017

37

1 reference

20 August 2017

6

1 reference

20 August 2017

354-359

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

20 August 2017

start time

31 December 2005

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

2001 annual report of the Korea Central Cancer Registry: based on registered data from 134 hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

The role of gelatinases in colorectal cancer progression and metastasis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Matrix metalloproteinases in colorectal cancer: is it worth talking about?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Role of matrix metalloproteinases (MMPs) in colorectal cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Matrix metalloproteinases: multifunctional contributors to tumor progression

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Effective surgical adjuvant therapy for high-risk rectal carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Metalloproteinases and cancer invasion.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785939

Host expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in normal colon tissue affects metastatic potential of colorectal cancer

2 September 2018

1 reference

12 December 2020

Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers

1 reference

12 December 2020

Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9

1 reference

12 December 2020

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

12 December 2020

Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas

1 reference

12 December 2020

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials

1 reference

12 December 2020

10.4143/CRT.2005.37.6.354

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19956372

1 reference